Corbus Pharmaceuticals Holdings, Inc. Equity-NMS: CRBP

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$4.92
Open :$4.75
Today's high :$5.04
Today's low :$4.68
52W low :$4.667
52W high :$61.9
EPS(TTM): :-3.68
Shares O/S :12.23 M
Market cap :61.41 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Corbus Pharmaceuticals Holdings, Inc. $5.02 +0.01% - 61.41M

Frequently Asked Questions

What is the share price of Corbus Pharmaceuticals Holdings, Inc. today?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.